SCHEMBL29762984

CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)O

nearest known ligand 0.61

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	14/20	0.61

▸	GIPR	P48546	14/20	0.61

▸	C5AR1	P21730	1/20	0.58

▸	CALCA	P06881	1/20	0.57

▸	CXCR4	P61073	3/20	0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29763090	1.00	GLP1R (0.61)	GLP1RGIPRC5AR1CALCACXCR4
SCHEMBL30665211	0.98	C5AR1 (0.59)	GLP1RGIPRC5AR1CALCACXCR4
SCHEMBL31119468	0.95	C5AR1 (0.56)	GLP1RGIPRC5AR1CALCACXCR4
SCHEMBL31119461	0.95	C5AR1 (0.56)	GLP1RGIPRC5AR1CALCACXCR4
SCHEMBL31058456	0.91	C5AR1 (0.56)	GLP1RGIPRC5AR1
SCHEMBL30490787	0.91	CALCA (0.57)	GLP1RGIPRCALCA
SCHEMBL31058453	0.90	GLP1R (0.55)	GLP1RGIPRC5AR1
SCHEMBL31703183	0.89	GLP1R (0.69)	GLP1RGIPR
SCHEMBL31182780	0.89	C5AR1 (0.66)	GLP1RGIPRC5AR1CXCR4
SCHEMBL31183030	0.89	NPY1R (0.67)	GLP1RGIPRCALCACXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4267104-A1	THERAPEUTIC PEPTIDE FORMULATIONS	Eli Lilly and Company (US)	2023-11-01	—	—	EP	claimed
WO-2022140373-A1	THERAPEUTIC PEPTIDE FORMULATIONS	ELI LILLY AND COMPANY (US)	2022-06-30	—	—	WO	claimed